Eli Lilly and CompanyvsNovartis

LLY and NVS stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,388.85

Value $1.31T

-1.81%
LLY's page

Eli Lilly and Company (LLY) has a market value of $1.31T and Novartis (NVS) $298B. Over the last year, with dividends, LLY moved +36.9% and NVS +22.5%. The P/E is 47.5 for LLY and 21.3 for NVS. Dividend yield: LLY 0.46%, NVS 2.62%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LLY$1.31T

    NVS$298B

    LLY is 4.4 times NVS

  • Revenue, 12 months

    LLY$86.5B

    NVS$54.5B

    LLY is 1.6 times NVS

  • Net income, 12 months

    LLY$27.6B

    NVS$14.0B

    LLY is 2.0 times NVS

  • Operating margin

    LLY–

    NVS32.4%

  • ROIC

    LLY35.5%

    NVS18.4%

    17.1 points apart

  • P/E

    LLY47.5

    NVS21.3

    LLY is 2.2 times NVS

  • Dividend yield

    LLY0.5%

    NVS2.6%

    2.1 points apart

  • 5-year return

    LLY+455.6%

    NVS+130.0%

    325.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LLY+455.6%

NVS+130.0%

20040060020222023202420252026
Returns by period
PeriodLLYWith dividendsNVSWith dividends
1 year since November 17, 2025+36.9%Price +36.0%+22.5%Price +18.8%
3 years since November 17, 2023+139.6%+33.8% a yearPrice +134.9%+82.6%+22.2% a yearPrice +64.7%
5 years since November 17, 2021+455.6%+40.9% a yearPrice +432.2%+130.0%+18.1% a yearPrice +90.9%
10 years since November 18, 2016+2,008.8%+35.6% a yearPrice +1,712.9%+255.7%+13.5% a yearPrice +147.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LLYEli Lilly and CompanyNVSNovartis

Valuation

LLYNVS
Valuation
Price$1,388.85$156.31
Market value$1.31T$298B
Enterprise value (EV)$1.35T$318B
P/E47.521.3
P/E, 5-year median49.916.6
P/B32.56.4
EV/EBIT39.018.0
Free cash flow yield1.5%5.9%

Results and growth

LLYNVS
Results and growth
Revenue, 12 months$86.5B$54.5B
Net income, 12 months$27.6B$14.0B
Free cash flow, 12 months$19.7B$17.6B
Earnings per share, 12 months$30.81$7.15
Revenue growth, year on year44.7%8.4%
Revenue growth a year, past+21.6%over 5 years+2.3%over 5 years
EPS growth a year, past+27.6%over 5 years+15.2%over 5 years

Margins and returns on capital

LLYNVS
Margins and returns on capital
Gross margin83.6%78.8%
Operating margin–32.4%
Net margin31.9%25.6%
ROIC35.5%18.4%
ROE88.6%30.0%

Balance sheet

LLYNVS
Balance sheet
Cash$4.9B$11.4B
Total debt$49.5B$31.4B
Net debt / EBITDA1.21.1
Interest cover38.9×15.4×

Dividends and buybacks

LLYNVS
Dividends and buybacks
Dividend yield0.5%2.6%
Dividend per share, 12 months$6.34$4.10
Dividend growth a year, past+15.2%over 5 years+5.4%over 5 years
Buyback yield0.3%3.1%
Shareholder yield0.8%5.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LLY or NVS

Didn't find what you were looking for?

Ask us
Which is bigger, Eli Lilly and Company or Novartis?

By market value, Eli Lilly and Company ($1.31T) is about 4.4 times Novartis ($298B), at today's prices.

How did LLY and NVS stock do over the last 10 years?

Since November 18, 2016, LLY's price moved +1,712.9% and NVS's +147.0%. With dividends: LLY +2,008.8% (+35.6% a year), NVS +255.7% (+13.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, LLY or NVS?

The dividend yield at today's price is 0.46% for Eli Lilly and Company and 2.62% for Novartis. Over the last twelve months they paid $6.34 and $4.10 per share.

What is the P/E of LLY and NVS?

At today's price, the P/E is 47.5 for LLY and 21.3 for NVS. The median of the last five years was 49.9 and 16.6, which shows where each stands against its own past.

Which has the higher profit margins, Eli Lilly and Company or Novartis?

Over the last twelve months, the net margin was 31.9% for Eli Lilly and Company and 25.6% for Novartis, and the operating margin – and 32.4%. Revenue was $86.5B and $54.5B.

Which is the better investment, Eli Lilly and Company or Novartis?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.